Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreeff

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemiasM A Schwartz, D R Lovett, A Redner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective studyS M Kornblau, M Andreeff, S X Hu, et al.
Oncogene|October 12, 2011
Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumorE Sugihara, T Shimizu, K Kojima, et al.
Blood|October 1, 1995
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host diseaseM Körbling, Y O Huh, A Durett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemiasI Tamm, S M Kornblau, H Segall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemiaS M Kornblau, E Estey, T Madden, et al.
Leukemia & Lymphoma|February 26, 1999
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphomaC R Bachier, R E Giles, D Ellerson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1997
Influenza among hospitalized adults with leukemiaH M Yousuf, J Englund, R Couch, et al.
Cell Death and Differentiation|May 19, 2007
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemiaJ Kuroda, S Kimura, A Strasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemiasM A Schwartz, D R Lovett, A Redner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective studyS M Kornblau, M Andreeff, S X Hu, et al.
Oncogene|October 12, 2011
Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumorE Sugihara, T Shimizu, K Kojima, et al.
Blood|October 1, 1995
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host diseaseM Körbling, Y O Huh, A Durett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemiasI Tamm, S M Kornblau, H Segall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemiaS M Kornblau, E Estey, T Madden, et al.
Leukemia & Lymphoma|February 26, 1999
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphomaC R Bachier, R E Giles, D Ellerson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1997
Influenza among hospitalized adults with leukemiaH M Yousuf, J Englund, R Couch, et al.
Cell Death and Differentiation|May 19, 2007
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemiaJ Kuroda, S Kimura, A Strasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
Pageof 32